Literature DB >> 10541258

Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.

H Sidhu1, M E Schmidt, J G Cornelius, S Thamilselvan, S R Khan, A Hesse, A B Peck.   

Abstract

Oxalobacter formigenes is a specific oxalate-degrading, anaerobic bacterium inhabiting the gastrointestinal tracts of vertebrates, including humans. This bacterium maintains an important symbiotic relationship with its host by regulating oxalate homeostasis, primarily by preventing enteric absorption. Increased absorption of oxalate can lead to multiple complications associated with hyperoxaluria, especially recurrent calcium oxalate urolithiasis. Detection of O. formigenes in the gastrointestinal tract has attracted attention because the absence of this bacterium appears to be a risk factor for development of hyperoxaluria and/or recurrent calcium oxalate kidney stone disease. In the present study, epidemiologic studies with patients at high risk for calcium oxalate urolithiasis showed a direct correlation between the number of recurrent kidney stone episodes and the lack of O. formigenes colonization. As expected, the lack of O. formigenes revealed a clear association with prophylactic antibiotic therapy. To confirm the importance of O. formigenes in regulating hyperoxaluria, laboratory rats known to be noncolonized were colonized with live bacteria or treated with a preparation of oxalate-degrading enzymes derived from O. formigenes to determine any subsequent increased resistance to high oxalate challenge. Rats receiving either bacteria or enzyme replacement therapy excreted far lower levels of oxalate, did not develop the crystalluria observed with control rats, and resisted the formation of calcium oxalate crystals in their nephrons. These observations, taken together, support the concept that O. formigenes is important in maintaining oxalate homeostasis, that its absence from the gut increases the risk for hyperoxaluria and recurrent kidney stone disease, and that replacement therapy is an efficient procedure to prevent hyperoxaluria and its complications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541258

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  67 in total

Review 1.  The impact of dietary oxalate on kidney stone formation.

Authors:  Ross P Holmes; Dean G Assimos
Journal:  Urol Res       Date:  2004-06-17

2.  Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation.

Authors:  John C Lieske; William J Tremaine; Claudio De Simone; Helen M O'Connor; Xujian Li; Eric J Bergstralh; David S Goldfarb
Journal:  Kidney Int       Date:  2010-08-25       Impact factor: 10.612

3.  Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.

Authors:  Kristin J Bergsland; Anna L Zisman; John R Asplin; Elaine M Worcester; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-01

4.  Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis.

Authors:  Aaron W Miller; David Choy; Kristina L Penniston; Dirk Lange
Journal:  Kidney Int       Date:  2019-02-28       Impact factor: 10.612

Review 5.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

Review 6.  The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

7.  Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes.

Authors:  Viktoria Kharlamb; Jennifer Schelker; Fritz Francois; Juquan Jiang; Ross P Holmes; David S Goldfarb
Journal:  J Endourol       Date:  2011-10-21       Impact factor: 2.942

Review 8.  Recent advances in the pathophysiology of nephrolithiasis.

Authors:  Khashayar Sakhaee
Journal:  Kidney Int       Date:  2008-12-10       Impact factor: 10.612

9.  Variability of Oxalobacter formigenes and oxalate in stool samples.

Authors:  Sergey Prokopovich; John Knight; Dean G Assimos; Ross P Holmes
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

10.  Formyl-CoA transferase encloses the CoA binding site at the interface of an interlocked dimer.

Authors:  Stefano Ricagno; Stefan Jonsson; Nigel Richards; Ylva Lindqvist
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.